Picture of Scope Fluidics SA logo

SCP Scope Fluidics SA News Story

0.000.00%
pl flag iconLast trade - 00:00
HealthcareBalancedSmall CapSucker Stock

Brief: Scope Fluidics Updates On PCR|ONE And BacterOMIC Development

July 10 (Reuters) - Scope Fluidics SA  SCPP.WA :
    * SEES POTENTIAL ISSUES WITH GATHERING SAMPLES FOR MRSA/SA
PANEL
TESTING UNDER PROJECT PCR|ONE DUE TO COVID-19 RESTRICTIONS IN
HOSPITAL LABS
    * SAYS HIGHLY LIKELY PRE-REGISTRATION TESTS ON MRSA/SA PANEL
WILL
BEGIN IN Q3
    * SAYS HAS BEGUN RECRUITMENT OF CENTRES TO CARRY OUT TESTS
ON
CLINICAL EFFICIENCY OF PCR|ONE SARS-COV-2 PANEL SYSTEM
    * SAYS UPHOLDS ACTION PLAN INDICATING CERTIFICATION FOR
PCR|ONE
-SARS-COV 2 PANEL WILL TAKE PLACE IN Q4
    * PLANS TO START EXTERNAL TESTS OF BACTEROMIC SYSTEM IN
SECOND
HALF OF JULY
    * TESTS TO DETERMINE EFFICIENCY OF BACTEROMIC SYSTEM
PROTOTYPE IN
EXTERNAL LAB IN ORDER TO IMPROVE DEVICE DIAGNOSTIC EFFICIENCY
    * SAYS WORKS ON PREREGISTRATION TEST STAGE FOR BACTEREOMIC
WILL BE
COMPLETED IN Q4

Source text for Eikon:  ID:nEM3CR13a 
Further company coverage:  SCPP.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Scope Fluidics SA

See all news